T1	Outcomes 304 324	locoregional control
T2	Outcomes 329 354	disease specific survival
T3	Outcomes 608 625	influence of EGFr
T4	Outcomes 630 663	histopathological differentiation
T5	Outcomes 673 711	overall treatment time of radiotherapy
T6	Outcomes 1079 1088	responded
T7	Outcomes 1276 1298	tumor differentiation.
T8	Outcomes 1362 1395	prominent separation of response:
T9	Outcomes 1436 1451	differentiation
T10	Outcomes 1694 1719	disease specific survival
T11	Outcomes 1826 1860	superior to conventional treatment
T12	Outcomes 1878 1886	response
T13	Outcomes 1933 1951	expression of EGFr
T14	Outcomes 1970 1992	tumor differentiation.
